Profile
Joseph Feder is the founder of ISTO Technologies, Inc. which was founded in 1997, where he held the title of Chairman from 2010 to 2014.
He was also the President, Chief Executive Officer & Director of Invitron Corp.
Dr. Feder's former job was as Director-Biochemistry & Cell Culture at Monsanto Co. from 1965 to 1989.
Dr. Feder earned a doctorate degree from Illinois Institute of Technology.
Former positions of Joseph Feder
Companies | Position | End |
---|---|---|
MONSANTO | Corporate Officer/Principal | 31/12/1988 |
Invitron Corp. | President | - |
ISTO Technologies, Inc.
ISTO Technologies, Inc. Medical SpecialtiesHealth Technology ISTO Technologies, Inc. develops and markets clinical solutions for spinal therapy, sports medicine, and trauma. It develops biologic products to rebuild bone, and heal degenerated or damaged cartilage. The company was founded by Joseph Feder and Scott Gill in 1997 and is headquartered in St. Louis, MO. | Founder | - |
Training of Joseph Feder
Illinois Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
ISTO Technologies, Inc.
ISTO Technologies, Inc. Medical SpecialtiesHealth Technology ISTO Technologies, Inc. develops and markets clinical solutions for spinal therapy, sports medicine, and trauma. It develops biologic products to rebuild bone, and heal degenerated or damaged cartilage. The company was founded by Joseph Feder and Scott Gill in 1997 and is headquartered in St. Louis, MO. | Health Technology |
Monsanto Co.
Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
Invitron Corp. | Commercial Services |
- Stock Market
- Insiders
- Joseph Feder